Gustave Roussy Foundation-CRIS Cancer Foundation Clinical Scientist Emerging Leader Programme.

Convocatorias


CRIS Cancer Foundation and Gustave Roussy Foundation are partnering to offer an exciting opportunity for a talented early career clinician scientist to develop their academic skills and expertise, placing them on a firm footing for a career as an independent clinical academic.

The aim of the GRF-CRIS Clinical Scientist Emerging Leader Programme is to provide competitive financial conditions and incentives for the early career of talented emerging young clinician scientists to lead projects, developing their research skills, academic skills, expertise and leadership on all types of cancer pathologies at the Gustave Roussy Institute.

This unique opportunity provides a pathway towards independence whilst facilitating collaborative research which ultimately translates to patient benefit.


Call for Applications 2025


In 2025, Gustave Roussy Foundation and CRIS Cancer run the first GRF-CRIS Clinical Scientist Emerging Leader Programme call, to award 1 research grant, covering a three-year period, for the purposes of incentivizing clinical scientists to develop their career at the Gustave Roussy Institute.

The maximum grant awarded will be €210,000, which will be spread over three annual instalments of up to €70,000 a year.

The call for applications opens on 1 January 2025 and closes on 28 February 2025 at 23:59 (Central European Time – CET).

All applications must be submitted by email to RLtrials@gustaveroussy.fr and convocatorias@criscancer.org during the application submission period for the 2025 call.

To download the Terms & Conditions of the call, click here

To download the needed Templates, click here